Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 137
Strategies to Leverage Research Funding: Guiding Dod’s Peer Reviewed Medical Research Programs C Workshop Agenda IOM COMMITTEE ON ALTERNATIVE FUNDING STRATEGIES FOR DOD’S PEER REVIEWED MEDICAL RESEARCH PROGRAMS April 26-27, 2004 Lecture Room, The National Academies 21st and C Streets, NW Washington, D.C. OPEN SESSION Monday, April 26 9-10:30 AM Greetings and opening statements about the charge to the committee by: Joseph Pagano, M.D., Committee Chair (9:00) Patricia Modrow, Ph.D., CDMRP Ovarian Cancer Research Program (9:15) Leo Giambarresi, Ph.D., CDMRP Prostate Cancer Research Program Manager Richard Kenyon, Ph.D., CDMRP Breast Cancer Research Program Manager
OCR for page 138
Strategies to Leverage Research Funding: Guiding Dod’s Peer Reviewed Medical Research Programs 10:30 AM12:15 PM PANEL 1: STAKEHOLDERS (Robert Cook-Deegan, Moderator) Fran Visco, President, National Breast Cancer Coalition Rick Atkins, M.D., President and CEO, National Prostate Cancer Coalition Ann Kolker, Executive Director, Ovarian Cancer National Alliance Michael Coburn, President and CEO, Tuberous Sclerosis Alliance Brenda Duffy, President, Neurofibromatosis, Inc. 1:15-3:00 PANEL 2: EXAMPLES OF PUBLIC PRIVATE RESEARCH FUNDING (Eric Campbell, Moderator) Amy McGuire, Executive Director, Foundation for the National Institutes of Health Robert Goldstein, M.D., Ph.D., Chief Scientific Officer, Juvenile Diabetes Research Foundation Gayle E. Lester, Ph.D., Program Director, Osteoarthritis Initiative Public-Private Initiative, NIAMS Carole A. Heilman, Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID Robert O’Keefe, Vice President, Health Effects Institute 3:00-3:15 Break 3:15-5:00 PANEL 3: PERSPECTIVES OF NONFEDERAL RESEARCH FUNDERS (Samuel Broder, Moderator) Alan Kinniburgh, Ph.D., Vice President, Medical & Scientific, Leukemia and Lymphoma Society Robert C. Wells, J.D., Vice President for Government Relations and Public Policy, Affymetrix, Inc. Ray Takigiku, Ph.D., Director of Core Technologies, Procter & Gamble Pharmaceuticals Donald C. Harrison, M.D., Senior Vice President and Provost for Health Affairs Emeritus, University of Cincinnati 5:00-5:30 Open microphone for public statements
OCR for page 139
Strategies to Leverage Research Funding: Guiding Dod’s Peer Reviewed Medical Research Programs Tuesday, April 27 8:30 AM Maria Freire, Ph.D., CEO, Global Alliance for TB Drug Development, on lessons learned from the TB Alliance experience about public-private partnerships in biomedical research (Dr. Freire was previously head of NIH’s Office of Technology Transfer) (introduced by MaryAnn Guerra) 9:15-10:00 Queta Bond, Ph.D., President, Burroughs-Wellcome Fund, on the roles of philanthropy and the federal government in biomedical research (introduced by Joseph Pagano) 10:00-10:15 Break 10:15 AM12:00 PM PANEL 4: PERSPECTIVES OF ACADEMIC RESEARCHERS AND RESEARCH ADMINISTRATORS (Thomas Caskey, Moderator) Mina J. Bissell, Ph.D., Distinguished Scientist/Life Sciences Division, Lawrence Berkeley National Laboratory Chung Lee, Ph.D., Professor of Urology, Cell and Molecular Biology and Director, Prostate Cancer Program, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Susan Ehringhaus, J.D., Associate General Counsel, Regulatory Affairs, Division of Biomedical & Health Sciences Research, Association of American Medical Colleges (former Vice Chancellor and General Counsel, UNC at Chapel Hill) Hank Gardner, Dr.P.H., Associate Vice President for Research and Professor, Environmental & Radiological Health Sciences, Colorado State University 1:00-2:45 PANEL 5: STATE PERSPECTIVES ON PUBLIC-PRIVATE RESEARCH COLLABORATION (Frank Samuel, Jr., Moderator) Dan Berglund, President and CEO, State Science and Technology Institute Frank E. Samuel, Jr., Science Advisor to the Governor of Ohio Marion H. E. Kavanaugh-Lynch, M.D., M.P.H., Director, California Breast Cancer Research Program Phillip A. Singerman, Ph.D., Executive Director, Maryland Technology Development Corporation Leslie M. Alexandre, Dr.P.H., President and Chief Executive Officer, North Carolina Biotechnology Center
OCR for page 140
Strategies to Leverage Research Funding: Guiding Dod’s Peer Reviewed Medical Research Programs 2:45-3:15 Robert D. Wells, Ph.D., President, Federation of American Societies of Experimental Biology, and Director, Center for Genome Research, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, on the role of public-private partnerships in biomedical research (introduced by Musa Mayer) 3:15-3:30 Break 3:30-4:15 J. Leighton Read, M.D., General Partner, Alloy Ventures, Palo Alto, CA, on the roles of public funding and venture capital in biomedical research and biotechnology (introduced by Thomas Caskey) 4:15-4:45 Andrew A. Toole, Ph.D., Assistant Professor, Department of Agriculture, Food and Resource Economics, Cook College, Rutgers University, on the economics of collaborative public-private research funding (introduced by Maryann Feldman) 4:45-5:00 Wrap-up 5:00 Adjourn
Representative terms from entire chapter: